Phase 1 trial of high-dose intravenous vitamin C treatment for patients with cancer
Stephenson, C.M.; Levin, R.D.; Lis, C.G.
Journal of the American Osteopathic Association 107(6): 212-213
2007
ISSN/ISBN: 0098-6151 PMID: 17635899 Document Number: 611303
Document emailed within 1 workday
Related Documents
Scarfone, G.; Villa, A.; Parazzini, F.; Sciatta, C.; Polverino, G.; Bolis, G. 1999: A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy Tumori 85(4): 217-219Madajewicz, S.; Petrelli, N.; Rustum, Y.M.; Campbell, J.; Herrera, L.; Mittelman, A.; Perry, A.; Creaven, P.J. 1984: Phase I-Ii trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer Cancer Research 44(10): 4667-4669
Lubetsky, A.; Shasha, Y.; Olchovsky, D.; Loebstein, R.; Halkin, H.; Ezra, D. 2003: Impact of pre-treatment INR level on the effect of intravenous low dose vitamin K in patients with excessive anticoagulation Thrombosis and Haemostasis 90(1): 71-76
Kasuya, H.; Kodera, Y.; Nakao, A.; Yamamura, K.; Gewen, T.; Zhiwen, W.; Hotta, Y.; Yamada, S.; Fujii, T.; Fukuda, S.; Tsurumaru, N.; Kuwahara, T.; Kikumori, T.; Koide, Y.; Fujimoto, Y.; Nakashima, T.; Hirooka, Y.; Shiku, H.; Tanaka, M.; Takesako, K.; Kondo, T.; Aleksic, B.; Kawashima, H.; Goto, H.; Nishiyama, Y. 2014: Phase i Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer Hepato-Gastroenterology 61(131): 599-605
Aabo, K.; Mortensen, S.A.; Skovsgaard, T.; Gymoese, E. 1983: Intermittent high-dose aclarubicin in patients with advanced cancer: a phase I study with special reference to cardiac toxicity Cancer Treatment Reports 67(3): 281-282
Isacoff, W.H.; Eilber, F.; Tabbarah, H.; Klein, P.; Dollinger, M.; Lemkin, S.; Sheehy, P.; Cone, L.; Rosenbloom, B.; Sieger, L.; Block, J.B. 1978: Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue Cancer Treatment Reports 62(9): 1295-1304
Hall, S.W.; Valdivieso, M.; Benjamin, R.S. 1977: Intermittent high single-dose ftorafur: phase i clinical trial with a pharmacologic-toxicity correlation Cancer Treatment Reports 61(8): 1495-1498
Buesa, J.M.; Mouridsen, H.T.; Santoro, A.; Somers, R.; Bramwell, V.; van Oosterom, A.T.; Wagener, T.; Vendrik, C.; Thomas, D. 1984: Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase Ii trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Cancer Treatment Reports 68(4): 683-684
Lehn, P.; Quessar, A.; Devergie, A.; Esperou-Bourdeau, H.; Traineau, R.; Trédaniel, J.; Benbunan, M.; Bussel, A.; Jolivet, I.; Mazeron, M.C. 1990: Treatment of severe cytomegalovirus infection with ganciclovir and high-dose intravenous immunoglobulin in patients with allogeneic bone marrow transplants. a pilot study Nouvelle Revue Francaise d'Hematologie 32(1): 17-20
Capizzi, R.L.; Powell, B.L. 1987: Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias Seminars in Oncology 14(2 Suppl 1: 40-50
Taneichi, H.; Miyawaki, T. 2011: High-dose intravenous immunoglobulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 69(3): 515-519
Bolis, G.; Scarfone, G.; Villa, A.; Acerboni, S.; Siliprandi, V.; Guarnerio, P. 1997: A phase i trial with fixed-dose carboplatin and escalating doses of paclitaxel in advanced ovarian cancer Seminars in Oncology 24(1 Suppl 2: S2
Dorval, T.; Beuzeboc, P.; Garcia-Giralt, E.; Jouve, M.; Livartowski, A.; Palangie, T.; Pouillart, P. 1993: Treatment of cancers of the ovary. Phase Ii trial of increase of the dose of cisplatin Presse Medicale 22(3): 104-108
Philalithis, P.E.; Joekes, A.M. 1974: High dose intravenous prednisolone in the treatment of glomerulonephritis Journal d'Urologie et de Nephrologie 80(12): 983-984
Huang, Y-juan.; Wu, Y-long.; Xie, S-xi.; Yang, J-ji.; Huang, Y-sheng.; Liao, R-qiang. 2007: Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial Chinese Medical Journal 120(6): 458-462
Fain, O.; Eclache, V.; Sitbon, M.; Thomas, M. 1996: Aseptic meningitis during treatment with high-dose intravenous immunoglobulins Presse Medicale 25(13): 643
Thimachai, P.; Supasyndh, O.; Chaiprasert, A.; Satirapoj, B. 2015: Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial Journal of the Medical Association of Thailand 98(7): 643-648
Yamada, S.; Wongwanakul, P. 2012: Randomized controlled trial of high dose bolus versus continuous intravenous infusion pantoprazole as an adjunct therapy to therapeutic endoscopy in massive bleeding peptic ulcer Journal of the Medical Association of Thailand 95(3): 349-357
Wilailak, S.; Tresukosol, D.; Linasmita, V.; Termrungruanglert, W. 2000: Phase Ii study of high-dose paclitaxel in platinum-refractory epithelial ovarian cancer European Journal of Gynaecological Oncology 21(6): 610-612
Locker, G.Y.; Khandekar, J.; Krauss, S.; Reisel, H.; Hoeltgen, T.; Wolter, J.; Haid, M.; Hoffman, R.; Blough, R.; Johnson, C. 1987: Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial Cancer Treatment Reports 71(6): 649-650